Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Many medically relevant bacteria cause severe human and animal diseases because they produce and release protein toxins that target mammalian cells. Because the toxin-induced cell damage is the reason for the clinical symptoms, the targeted pharmacological inhibition of the cytotoxic mode of action of bacterial toxins should prevent or cure the respective toxin-associated disease. Toxin inhibitors might be beneficial when the toxin acts in the absence of the producing bacteria (e.g., food poisoning), but also in combination with antibiotics in infectious diseases when the toxin-producing bacteria are present. The focus of this Special Issue of Toxins is on the development and characterization of novel inhibitors against bacterial toxins, e.g., toxin neutralizing antibodies, peptides or small compounds, as well as toxin pore blockers, which interfere with bacterial toxins and thereby protect cells from intoxication.

Bacterial proteins. --- Bacterial toxins.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Bacterial toxins. --- Bacterial Toxins.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Bacterial spores --- Spores, Bacterial

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Bacterial genomes.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Annotation Bridging cellular membranes is a key step in the pathogenic action of both binary and pore-forming bacterial toxins. The former use their translocation domains, containing various structural motifs, to ensure efficient delivery of the toxic component into the host cell, while the latter act on the cellular membrane itself. In either case, the integrity of the membrane is compromised via targeted protein-lipid and protein-protein interactions triggered by specific signals, such as proteolytic cleavage or endosomal acidification. This Special Issue presents recent advances in characterizing functional, structural and thermodynamic aspects of the conformational switching and membrane interactions involved in the cellular entry of bacterial protein toxins. Deciphering the physicochemical principles underlying these processes is also a prerequisite for the use of protein engineering to develop toxin-based molecular vehicles capable of targeted delivery of therapeutic agents to tumors and other diseased tissues.

Bacterial toxins.